
- Volume 0 0
Rx COPAY INCREASES MAY BACKFIRE ON COST CUTTERS
Employers hoping to reduce the rising cost of employeehealth coverage should think twice before raising prescriptiondrug copays for workers, researchers at Carnegie MellonUniversity found in a new study of health care expenses.
?What most employers don?t consider is that increasedcopays on drugs may lead to an increase in other types ofhealth care,? explained a spokesman for the researchers.
The authors of the study, published recently in Forum forHealth Economics and Policy, concluded that when prescriptioncopays rise employees react by buying fewer drugs, savingmoney for the employer. The higher copay requirements,however, also encourage workers to rely on health care ?substitutions.?This result leads to increased physician or emergencyroom visits, which are more costly in the long run.
Articles in this issue
about 18 years ago
Calming the Symptoms of Menopauseabout 18 years ago
Zoster Vaccineabout 18 years ago
pharmacy TECHNOLOGY productsabout 18 years ago
health-systems PRODUCT newsabout 18 years ago
can you READ these Rxs?about 18 years ago
can you READ these Rxs?about 18 years ago
Generic Times Product Newsabout 18 years ago
compounding HOTLINEabout 18 years ago
Human HRT Leads Compounding Renaissanceabout 18 years ago
Prescription-overdose Deaths Surpass Car-accident DeathsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.















































































































































































































